Bibliography (34):

1. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomized, phase 3 trial

2. https://clinicaltrials.gov/study/NCT03954834

3. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes [SURPASS-2]

4. https://clinicaltrials.gov/study/NCT03987919

5. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomized, open-label, parallel-group, phase 3 trial

6. https://clinicaltrials.gov/study/NCT03882970

7. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomized, open-label, parallel-group, multicenter, phase 3 trial

8. https://clinicaltrials.gov/study/NCT03730662

9. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial

10. https://clinicaltrials.gov/study/NCT04039503

11. Lilly’s tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1

12. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicenter, randomized, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

13. FDA approves first oral GLP-1 treatment for type 2 diabetes

14. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4mg for weight management: a randomized, controlled, phase 1b trial

15. Wikipedia Bibliography:

    1. Glycated hemoglobin

    2. Statistical-significance

    3. https://en.wikipedia.org/wiki/Diabetes  :

       https://en.wikipedia.org/wiki/Diabetes

    4. Food and Drug Administration

    5. Tirzepatide

    6. Glucose-dependent insulinotropic polypeptide

    7. Glucagon-like peptide-1

    8. https://en.wikipedia.org/wiki/Diabetes_management#Glycemic_control  :

       https://en.wikipedia.org/wiki/Diabetes_management#Glycemic_control

    9. Type 2 diabetes

    10. https://en.wikipedia.org/wiki/Pancreatitis  :

        https://en.wikipedia.org/wiki/Pancreatitis

    11. https://en.wikipedia.org/wiki/Type_1_diabetes  :

        https://en.wikipedia.org/wiki/Type_1_diabetes

    12. https://en.wikipedia.org/wiki/Incretin  :

        https://en.wikipedia.org/wiki/Incretin

    13. https://en.wikipedia.org/wiki/Autoinjector  :

        https://en.wikipedia.org/wiki/Autoinjector

    14. https://en.wikipedia.org/wiki/Injector_pen  :

        https://en.wikipedia.org/wiki/Injector_pen

    15. Semaglutide

    16. https://en.wikipedia.org/wiki/Insulin_glargine  :

        https://en.wikipedia.org/wiki/Insulin_glargine

    17. https://en.wikipedia.org/wiki/Insulin_degludec  :

        https://en.wikipedia.org/wiki/Insulin_degludec

    18. Metformin

    19. https://en.wikipedia.org/wiki/SGLT2_inhibitor  :

        https://en.wikipedia.org/wiki/SGLT2_inhibitor

    20. https://en.wikipedia.org/wiki/Sulfonylurea  :

        https://en.wikipedia.org/wiki/Sulfonylurea